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Differences in cervical cancer screening between immigrants
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The prevalence of cervical cancer is high among some
groups of immigrants. Although there is evidence of low
participation in cervical cancer screening programs among
immigrants, studies have been subject to selection bias and
accounted for few immigrant groups. The aim of this study
was to compare the proportion of several groups of
immigrants versus nonimmigrants attending the cervical
cancer-screening program in Norway. In addition, we aimed
to study predictors for attendance to the screening program.
Register-based study using merged data from four national
registries. All Norwegian-born women (1 168 832) and
immigrant women (152 800) of screening age for cervical
cancer (25–69 years) registered in Norway in 2008 were
included. We grouped the immigrants by world’s geographic
region and carried out descriptive analyses and constructed
several logistic regression models. The main outcome
variable was whether the woman was registered with a Pap
smear in 2008 or not. Immigrants had lower rates of
participation compared with Norwegian-born women;
Western Europe [adjusted odds ratio (OR), 95% confidence
interval (CI): 0.84, 0.81–0.88], Eastern Europe (OR 0.64, 95%
CI: 0.60–0.67), Asia (OR 0.74, 95% CI: 0.71–0.77), Africa (OR
0.61, 95% CI: 0.56–0.67) and South America (OR 0.87, 95%
CI: 0.79–0.96). Younger age, higher income, residence in
rural areas, and having a female general practitioner (GP)
were associated with Pap smear. Longer residential time in
Norway and having a nonimmigrant GP were associated
with screening for some immigrant groups. Appropriate
interventions targeting both immigrants and GPs need to be
developed and evaluated. European Journal of Cancer
Prevention 00:000–000 Copyright © 2016 Wolters Kluwer
Health, Inc. All rights reserved.
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Introduction
Cervical cancer is one of the few preventable cancers if
detected early. It is the third most common cancer and
the fourth most frequent cause of cancer deaths in
women worldwide (Jemal et al., 2011). However, cervical
cancer prevalence and mortality are not evenly dis-
tributed. More than 85% of the cases and deaths occur in
low-income and middle-income countries (Ferlay et al.,
2013). Cervix cancer is slightly more common in some
immigrant groups living in Western countries than in the
general population (Arnold et al., 2010; Azerkan et al.,
2012).
The main factor for the development of cervical cancer is
persistent infection with high-risk human papilloma
virus. Many Western countries use the Papanicolaou stain
(Pap smear) for cervical cancer screening (CCS). Several
international studies show that immigrants have lower
participation rates in preventive screening (Woltman and
Newbold, 2007; Johnson et al., 2008; Lofters et al., 2010;
Grandahl et al., 2012; Berens et al., 2014; Campari et al.,
2015; Ghebre et al., 2015; Lee et al., 2015) and when they
eventually see a doctor, they are often diagnosed with
severe forms of cervical cancer (Schleicher, 2007).
However, these studies are often subject to selection
bias, limited to one immigrant group or ethnic group, and
rely on self-reported data.
Nearly 16% of the population in Norway was of migrant
origin at the beginning of 2016 (Statistics Norway, 2016).
In Norway, today, all women between 25 and 69 years
receive a letter in Norwegian at 3-year intervals, inviting
them to make an appointment with their general practi-
tioner (GP) to take a Pap smear. Although the general
attendance to this program has been 74% after reminders
(Skare and Lönnberg, 2015), over half of the women
diagnosed with cervical cancer have rarely or never taken
a Pap smear (Cancer Registry of Norway, 2016). The
proportion of women with immigrant background who
attend this program is currently unknown.
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Our hypothesis was that immigrants in Norway had lower
but different attendance rates of CCS depending on their
region of origin. In addition, we hypothesized that not
only the characteristics of the women but also those of
their GPs could influence women’s attendance to CCS.
We took advantage of a nationwide multiregister study
including information on all women registered in Norway
and their GPs. Our aim was to compare the proportion of
different groups of immigrants with nonimmigrant
women registered by their GPs as having taken a Pap
smear in 2008 and to study predictors for attendance to
the CCS program for the different immigrant groups.
Participants and methods
This was a cross-sectional study using merged data from
four nationwide registries in Norway: The National
Population Registry, the Norwegian Health Economics
Administration Database (HELFO), the GPs’ database,
and the 2008 Medical Birth Registry.
All Norwegian citizens and legal immigrants residing in
Norway for over 6 months have a unique personal iden-
tification number and this was used to link the four
registries. All legally registered immigrants are members
of the National Insurance Scheme, which entitles them
access to a GP and Emergency Primary Care services. All
nonimmigrant women with both parents from Norway
(1 168 832) and immigrant women defined as born abroad
with both parents from abroad (152 800) in the age group
for CCS (25–69 years) registered in Norway in 2008 were
included in the study.
From the National Population Registry, we obtained infor-
mation on study women in terms of age, immigration cate-
gory (nonimmigrant or immigrant), reason for migration
(refugee, work, family reunification, and other), length of stay
in Norway (up to 2 years and longer than 2 years), municipal
centrality (urban or rural), civil status (married, unmarried,
and other – including widowed, divorced, separated, and
others), education level (none, low: lower secondary school,
middle: upper secondary school, and high: university/col-
lege), and personal annual income in Norwegian Kroners
(NOK) (low: below 200 000 NOK, medium, and high: over
400 000 NOK). Immigrant’s country of origin was categor-
ized by regions as follows: (i) Nordic countries, (ii) North
America and Western Europe, (iii) Eastern Europe, (iv) Asia,
(v) Africa, and (vi) South and Central America. As pre-
liminary analyses showed similar results for Nordic countries
andWestern Europe/North America and for comparison with
other studies, we regrouped these two regions into one called
‘Western Europe’.
HELFO data (HELFO, Tønsberg, Norway) were based
on administrative claims registered from all patient con-
tacts within the primary healthcare, including both con-
sultations with GPs and Emergency Primary Care
services. Diagnoses were based on the International
Classification of Primary Care, version 2 (ICPC-2). For
our study, we selected consultations with diagnoses
related to screening for cervical cancer. The diagnoses
included were X85 disease in cervix IKA, X86 abnormal
cervical cytology, A981 cytology cervical screening, and
37 histological/cytological test and other gynecological
illnesses. We created a binary variable as the main out-
come variable, being ‘1’ for women with at least one of
these diagnoses and ‘0’ for the rest of the women.
We obtained information from the Medical Birth Registry
on whether the woman had given birth or not in 2008.
From the GPs’ database, we obtained information on sex
and immigrant background of the women’s GP.
This study is part of the project ‘Immigrants’ Health in
Norway’, approved by the Regional Committee for
Medical and Health Research Ethics and the Norwegian
Data Inspectorate.
Statistical analyses
We performed comparisons of demographic character-
istics for nonimmigrants and immigrants using χ2 and
analysis of variance for categorical and continuous vari-
ables, respectively. In addition, we compared the
demographic characteristics of women with and without a
Pap smear test for each of the regions of origin.
Binary logistic regression analyses were carried out with
‘being registered with a Pap smear test in 2008’ as the
dependent variable. Our main explanatory variable was
the patients’ region of origin, with nonimmigrants as the
reference group. Other explanatory variables included the
woman’s age, income, marital status, municipal centrality,
pregnancy, and GP’s characteristics. We constructed
several logistic regression models. First, we included each
of the explanatory variables one by one. Model 1 included
age categorized into three intervals in addition to region of
origin. Model 2 added other socioeconomic variables:
marital status, income, and municipality’s centrality to
model 1. Model 3 further included GP’s sex and immi-
grant background. We used pregnancy in the preliminary
analyses, but did not include it afterwards as the inclusion
of this variable did not further improve the model mea-
sured by the Nagelkerke R2 value.
Finally, to explore effect modifications between region of
origin and the other explanatory variables, we performed
binary logistic regression of model 3 by region of origin.
We used SPSS 22.0 software package for statistical ana-
lyses. (SPSS - Statistical package for social sciences), IBM
Corp. 2013. Armonk, New York, USA).
Results
A total of 1 321 632 women with a mean age of 47.1 years
(SD 12.6) were included in our study. Table 1 describes
the sociodemographic characteristics of the study popu-
lation by regional groups.
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Immigrants had lived in Norway from 8 to 18 years.
Compared with nonimmigrants, immigrant women were
younger and more often lived in urban areas. Women
from Western Europe had the highest income and edu-
cation levels, whereas more than half of the women from
Africa had either low or no reported education and had
the lowest income levels. Women from Eastern Europe,
Asia, and South America were often unmarried. A higher
percentage of immigrants had been pregnant in 2008.
Those from Asia more often had female GPs. Immigrants
more often had GPs born outside Norway. Of the total
7.4% Pap smear registered in 2008, the highest registra-
tion was made among nonimmigrant women (7.7%) and
the lowest among immigrant women from Africa and
Eastern Europe (4.6%).
Demographic characteristics for women, both with and
without Pap smear by region of origin, are presented as
Supplementary data (Table S1), Supplemental digital
content 1, http://links.lww.com/EJCP/A118. For both
immigrants and nonimmigrants, younger women, with
higher income, in rural areas and those who had not been
pregnant were among those who took Pap smear more
often. Among immigrants, no significant differences in
taking Pap smears were observed by length of stay.
Generally, women with female GPs had more Pap smears
registered. The proportion of women with a Pap smear
was significantly lower among women with an immigrant
GP, except for women from Africa.
Table 2 shows the results from logistic regression ana-
lyses. Immigrants from all regions had a significantly
lower probability of having a Pap smear registered com-
pared with nonimmigrants in all models. Increasing age
was associated negatively with Pap smear rates. Higher
income, living in rural areas, having a female GP, and a
Norwegian GP were associated significantly with more
Pap smears in multivariate models. Although being
married was associated with a Pap smear test in univariate
analyses, the opposite was true in the adjusted models.
Table 3 shows the adjusted logistic regression analyses for
immigrant women by region of origin. The associations
between screening and socioeconomic variables were in
the same direction as for the population as a whole in
terms of income and living in rural areas, but differed
slightly for the various immigrant groups for other char-
acteristics. Younger age was associated significantly with
Pap smear for women from Eastern Europe and the age
pattern seemed to be different for women from Asia,
where women aged 41–55 years took the test significantly
more often. The effect of length of stay in Norway on
screening varied with the immigrant group, being posi-
tively associated for women from Eastern Europe,
whereas most other groups had significantly lower atten-
dance after 2 years. Being single was positively associated
for women from Eastern Europe, Asia, and South
America, whereas being married was associated with
lower rates of Pap smears for women from Asia and South
Table 1 Sociodemographic characteristics of the study population by world regions
Norway Western Europea Eastern Europe Asia Africa South Americab
Age [mean (SD)] 47.1 (12.6) 45.1 (12.7) 39.1 (10.9) 39.5 (10.5) 37.2 (9.3) 40.2 (10.7)
Length of stay [mean (SD)] – 17.5 (14.9) 8.6 (8.6) 12.0 (9.5) 9.5 (8.4) 12.5 (10.1)
Income (%)
Low 38.5 41.5 53.2 64.4 72.5 56.6
Medium 42.2 35.2 35.8 28.3 22.3 34.0
High 19.4 23.3 11.1 7.3 5.2 9.3
Education (%)
No education 0.1 0.3 0.8 5.1 9.5 1.5
Low 21.7 14.1 26.8 43.0 46.2 29.5
Middle 43.2 28.8 30.3 25.2 26.7 34.8
High 35.0 56.8 42.2 26.7 17.6 34.2
Municipal centrality (%)
Rural 34.3 23.0 24.9 15.7 15.1 17.6
Urban 65.7 77.0 75.1 84.3 84.9 82.4
Marital status (%)
Married 27.3 28.8 18.0 10.2 17.8 15.0
Unmarried 53.4 54.7 64.9 72.4 55.2 61.2
Others 19.4 16.4 17.0 17.4 27.0 23.8
Gave birth in 2008 or 2009 (%)
Yes 5.7 7.7 9.8 10.1 17.6 9.9
GP’s sex (%)
Male 62.2 62.5 63.6 54.4 62.0 66.8
Female 37.8 37.5 36.4 45.6 38.0 33.2
GP’s origin (%)
Born in Norway 76.4 66.1 54.8 57.4 58.1 63.4
Born abroad 23.6 33.9 45.2 42.6 41.9 36.6
Registered Pap smear in 2008 by GP (%)
Yes 7.7 6.0 4.6 5.7 4.6 6.3
Number of observations 1 168 832 40 761 35 046 55 866 14 008 7119
GP, general practitioner.
aWestern Europe also includes Nordic countries and North America.
bSouth America includes Central America.
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America. In terms of GP’s characteristics, having a female
GP significantly increased the probability of taking a Pap
smear for all groups, whereas having a GP born outside
Norway was associated with significantly lower rates of
Pap smear for Europeans and Asians, but not for women
from Africa and South America.
Discussion
Our study confirms lower rates of participation in the
preventive CCS program in Norway among immigrants
compared with nonimmigrants. Higher income, resi-
dence in rural areas, and having a female GP were asso-
ciated positively with Pap smear for both immigrants and
nonimmigrants. Younger age was associated with Pap
smears for nonimmigrants and most immigrant groups.
Longer stay in Norway was significantly positively asso-
ciated with higher attendance for women from Eastern
Europe, but not for other immigrants. Having a
Norwegian-born doctor was positively associated with
screening for women from Western and Eastern Europe
and Asia, but not for women from Africa or South
America.
Our findings are in agreement with several international
studies that report lower rates of CCS for immigrants
(Woltman and Newbold, 2007; Lofters et al., 2010;
Berens et al., 2014; Campari et al., 2015; Ghebre et al.,
2015; Lee et al., 2015), but with wide variations in
screening by ethnic background (McDonald and
Kennedy, 2007). In our study, women from Africa and
Eastern Europe had the lowest rates of participation in
CCS. Given the nature of our study, we cannot provide
explanations for this finding, but several barriers descri-
bed earlier could contribute toward explaining our
results. We group these barriers into individual (including
cultural, economic, and life situation related) and
structural.
Cultural barriers mentioned in other studies include the
belief that the healthcare system is for treatment not for
prevention (Akers et al., 2007), embarrassment, and the
fear that screening threatens virginity (Coughlin et al.,
2006; Akers et al., 2007). These barriers might, however,
influence immigrants differentially. Embarrassment
regarding circumcision, for example, can be especially
important for women from Somalia (Lofters et al., 2011;
Shelton et al., 2012; Ekechi et al., 2014; Harcourt et al.,
2014), who represent the main group among women from
Africa in our study.
Table 2 Binary logistic regression. Associations between Pap-smear attendance and immigrant background
Models
Unadjusted Model 1 Model 2 Model 3
Adjusted OR 95% CI Adjusted OR 95% CI Adjusted OR 95% CI Adjusted OR 95% CI
Origin
Norway (reference) 1 1 1 1 1
West Europe 0.78 0.75–0.81 0.76 0.73–0.80 0.79 0.76–0.82 0.84 0.81–0.88
East Europe 0.58 0.55–0.61 0.54 0.51–0.57 0.56 0.53–0.59 0.64 0.60–0.67
Asia 0.73 0.70–0.76 0.68 0.66–0.71 0.73 0.71–0.76 0.74 0.71–0.77
Africa 0.58 0.53–0.62 0.53 0.49–0.57 0.59 0.54–0.64 0.61 0.56–0.67
South America 0.80 0.73–0.89 0.75 0.69–0.83 0.80 0.73–0.89 0.87 0.79–0.96
Age in years
25–40 (reference) 1 1 1 1
41–55 0.95 0.94–0.97 0.93 0.91–0.94 0.89 0.88–0.91 0.91 0.89–0.92
56–75 0.75 0.74–0.77 0.72 0.71–0.73 0.73 0.72–0.75 0.75 0.74–0.77
Marital status
Married (reference) 1 1 1
Unmarried 0.99 0.97–1.00 1.12 1.10–1.14 1.12 1.10–1.14
Other 0.87 0.86–0.89 1.03 1.01–1.05 1.05 1.02–1.07
Income
Low 1 1 1
Medium 1.34 1.32–1.36 1.22 1.20–1.24 1.19 1.17–1.21
High 1.29 1.27–1.31 1.21 1.19–1.23 1.16 1.14–1.18
Municipal centrality
Rural 1 1 1
Urban 0.82 0.80–0.83 0.82 0.81–0.83 0.80 0.79–0.81
GP’s sex
Male 1 1
Female 1.70 1.68–1.73 1.70 1.67–1.72
GP’s origin
Norway 1 1
Born abroad 0.88 0.86–0.89 0.89 0.88–0.91
Nagelkerke 0.005 0.008 0.019
Unadjusted: includes one variable at the time.
Model 1: includes age in three categories in addition to region of origin.
Model 2: added other socioeconomic variables: marital status, income, and municipality’s centrality to model 1.
Model 3: includes GP’s sex and immigrant background in addition to models 1 and 2.
95% CI, 95% confidence interval; GP, general practitioner; OR, odds ratio.
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However, culture and beliefs are not static, and accul-
turation tends to increase with longer stay in the new
country. Although several studies describe a positive
association between longer stay in the host country and
Pap smear (McPhee et al., 1997; Lofters et al., 2011), other
studies find that disparities in CCS attendance persist
despite longer stay in the host country (Echeverria and
Carrasquillo, 2006). In our study, length of stay in Norway
was positively associated with screening for women from
Eastern Europe, but negatively associated for women from
Western Europe, Africa, and South America, despite dif-
ferent cut-offs of length of stay used in the analyses
(Supplementary Table 2, Supplemental digital content 2,
http://links.lww.com/EJCP/A119). This indicates an effect
modification between length of stay and attendance for the
different immigrant groups. Women from Poland represent
the majority of immigrant women from Eastern Europe. A
possible explanation for the association between length of
stay and Pap smear for Eastern Europeans could be that
these women prefer direct access to specialist healthcare as
in their home countries compared with gatekeeping by
GPs in Norway and might therefore travel to their own
country to receive healthcare services during the first years
in Norway (Lamkaddem et al., 2012).
Economical barriers such as patient charges to obtain
health services may have a greater impact on women with
low income. Immigrant women’s life situation such as
taking care of the elderly and children, language barriers in
the new host country, and lack of knowledge of cancer and
screening programs might also prevent them from partici-
pating in screening programs (Grandahl et al., 2012). In our
study, the association between being married and screen-
ing attendance varied for the different immigrant groups.
Unmarried women from Eastern Europe, Asia, and South
America took more Pap smear than married women from
the same areas. Most of the previous studies showed that
younger women take more Pap smears than older women,
but information on marital status and Pap smear had been
scarce. One report from British Columbia showed a posi-
tive association between being married and Pap smear for
immigrants (Fletcher, 2011).
Our result showing that women in rural areas take more
Pap smear was consistent for all groups. This is, to our
knowledge, a new finding not described before.
Immigrant women from rural areas tend to be better
integrated into society and rural GPs have lower numbers
of patients. As a result, information on and availability of
the system might be higher.
Structural barriers include those related to physicians and
the availability of the health system in the host country.
Among the GP characteristics in our study, the main
factor that was positively associated with Pap smear was
having a female GP. There are other studies that show
similar findings both related to women’s preferences
(Nguyen et al., 2002), but also to female GPs more
actively asking new patients whether they have had a Pap
Table 3 Binary logistic regression. Pap-smear attendance for immigrant women by region of origin
Western Europea Eastern Europe Asia Africa South Americab
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age
25–40 (reference) 1 1 1 1 1
41–55 0.94 0.85–1.04 0.78 0.69–0.88 1.09 1.01–1.18 1.07 0.88–1.29 0.86 0.69–1.07
56–75 0.74 0.65–0.84 0.60 0.48–0.74 0.61 0.51–0.72 0.63 0.39–1.01 0.70 0.48–1.02
Stay in Norway (years)
0–2 1 1 1 1 1
Above 2 0.86 0.76–0.98 1.17 1.02–1.33 0.93 0.82–1.04 0.74 0.59–0.92 0.74 0.56–0.98
Marital status
Married 1 1 1 1 1
Unmarried 1.06 0.96–1.18 1.19 1.02–1.38 1.68 1.44–1.99 0.98 0.78–1.22 1.41 1.02–1.94
Others 0.98 0.84–1.13 1.19 0.99–1.44 1.56 1.30–1.86 0.90 0.69–1.16 1.58 1.10–2.27
Income
Low 1 1 1 1 1
Medium 1.23 1.11–1.35 1.25 1.12–1.40 1.26 1.16–1.37 1.42 1.18–1.71 1.26 1.02–1.57
High 1.04 0.93–1.17 0.99 0.83–1.18 1.23 1.07–1.41 1.11 0.77–1.62 1.12 0.79–1.58
Municipal centrality
Rural 1 1 1 1 1
Urban 0.84 0.76–0.93 0.76 0.68–0.86 0.82 0.74–0.90 0.77 0.62–0.96 0.83 0.64–1.06
GP’s sex
Male 1 1 1 1 1
Female 1.81 1.66–1.96 1.87 1.68–2.07 1.73 1.61–1.87 1.50 1.27–1.77 1.40 1.15–1.73
GP’s origin
Norway 1 1 1 1 1
Born abroad 0.88 0.80–0.97 0.85 0.76–0.95 0.87 0.80–0.94 1.07 0.91–1.27 0.83 0.67–1.03
Nagelkerke R2 0.020 0.023 0.021 0.013 0.013
Number of observations 37 068 30 587 51 908 12 998 6558
Results adjusted for all the variables in the table.
95% CI, 95% confidence interval; GP, general practitioner; OR, odds ratio.
aWestern Europe also includes Nordic countries and North America.
bSouth America includes Central America.
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smear (Harcourt et al., 2014). This may also be the case in
Norway. A recommendation by the GP has been descri-
bed previously as an important facilitator to cancer
screening (de Alba and Sweningson, 2006). Our study
points to a lower screening attendance among women
who have a GP with an immigrant background. This is in
agreement with other studies suggesting that when the
physician and the patient have the same immigrant
background or ethnicity, the rate of CCS is reduced
(McPhee et al., 1997). In addition, lack of time to discuss
screening and to communicate with the patient in a
culturally appropriate way are mechanisms described to
explain the low rate of CCS among immigrants (de Alba
and Sweningson, 2006; Akers et al., 2007).
Strength and limitations of the study
Our study has several strengths. First, it is register based
and includes over one million women. By including all
the women registered in 2008 as having had a Pap smear,
we avoid self-selection bias and by using GPs registration
of tests, recall bias or errors with respect to diagnosis are
minimal. Furthermore, grouping immigrant women by
major world regions, we disentangled some of the dif-
ferences between immigrant groups. Patterns observed
among different immigrant groups in Norway are likely to
be applicable to other Western countries.
However, our study also has limitations. The world regions
that we use can be quite heterogeneous as they include
many countries, religions, and cultures. GPs have a gate-
keeper function in Norway and they take most of the Pap
smears, but Pap smears taken by gynecologists or other
health providers were not included in our data. However,
women cannot seek a public gynecologist without a referral
from a GP. Because we are using HELFO’s diagnosis
system, we are dependent on GPs registering the Pap
smears correctly. Some women might not be registered if
they visit their GP for other reasons even though the
consultation resulted in taking a Pap smear. For example,
when a woman comes to see her GP for irregular bleeding,
the diagnosis of menorrhagia is made even though the GP
takes a Pap smear. Last but not the least, screening in
Norway is recommended every 3 years, whereas we have
studied Pap smear for only 1 year (2008). The lack of
registration when several diagnoses are discussed in the
consultation is probably the main reason for the dis-
crepancy between our numbers (7.7% in 2008) and the
∼64% (around 20% per year) of women who take a Pap
smear in a given year. However, on the basis of several
other studies using HELFO data, there is no indication
that GP’s registration is different for immigrants and non-
immigrants. Thus, we believe that these shortcomings will
not change our results as our aim is not to determine the
prevalence, but to compare the proportion of screening
among nonimmigrants and immigrants.
Implication for clinical practice
Our findings indicate the need for policy makers to
develop and implement measures targeting the prevention
of cervical cancer among immigrants. Increased awareness
among primary care providers of low attendance among
immigrants is required to increase participation of immi-
grants to preventive programs. GPs and other health pro-
viders need to know and learn more about barriers related
to sex, communication, and culture to address these in an
appropriate way.
Conclusion
The participation of immigrant women to CCS in
Norway must be increased. Appropriate interventions
targeting both immigrant women and care providers need
to be developed and evaluated. User participation and
seeking information from immigrant women and health-
care personnel could further shed light on potential bar-
riers and to decrease the screening gap between
immigrants and nonimmigrants.
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